OakChart

Arcadia Biosciences Inc

RKDAConsumer Defensive·Packaged Foods·USA·Nano·NASD·Nov 11 • 10:46 AM ET

0.1587-0.0063 (-3.82%)
2026-11-11 17:18 CET
Market cap
0.40 USD m
Revenue, TTM
4.75 USD m
Net income, TTM
-11.13 USD m
Free cash flow, TTM
-2.54 USD m
EPS diluted, TTM
-4.55
P/E
-
Compare

Price

RKDA against its 20, 50 and 200-day averages
2050200earnings
0.001.002.003.0061.1M122.3MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26RKDAclose 0.1620-day 0.1650-day 0.28200-day 0.930.16

95.9% under the 52-week high of 3.87 on 14 Nov 2025. 52-week low 0.11 on 19 Oct 2026. Last 15 sessions, 34.1% high to low

Profile

RKDA
52-week range, 1% of the way up
0.113.87

Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. The firm uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include Zola coconut water and agronomic wheat traits. It operates through the following geographical segments: United States, Argentina, India, and Canada. The company was founded by John G. Sperling in 2002 and is headquartered in Dallas, TX.

Employees8
IPOMay 15, 2015
Beta0.57
ATR, 14d0.03
Rel volume0.13
Short float5.69%
Insider own15.87%
Inst own18.11%

Snapshot

6 groups

Valuation

Index-
Market Cap0.38M
Enterprise Value-3.80M
Income-11.13M
Sales4.75M
Book/sh0.29
Cash/sh1.72
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees8
IPOMay 15, 2015

Ratios

P/E-
Forward P/E-
PEG-
P/S0.08
P/B0.55
P/C0.09
P/FCF-
EV/EBITDA-
EV/Sales-0.80
Quick Ratio2.92
Current Ratio3.49
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortNo / Yes

Earnings

EPS (ttm)-4.55
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y59.46% 38.02%
Sales past 3/5Y-13.16% -9.57%
EPS Y/Y TTM17.56%
Sales Y/Y TTM-12.24%
EPS Q/Q35.79%
Sales Q/Q-0.82%
EarningsAug 13 AMC
EPS/Sales Surpr.- -

Ownership

Insider Own15.87%
Insider Trans0.00%
Inst Own18.11%
Inst Trans18.73%
ROA-162.72%
ROE-430.93%
ROIC-1758.45%
Gross Margin34.58%
Oper. Margin-85.52%
Profit Margin-234.53%
SMA20-1.79%
SMA50-44.17%
SMA200-82.85%
Trades-

Technical

Shs Outstand2.18M
Shs Float2.03M
Short Float5.69%
Short Ratio0.06
Short Interest0.12M
52W High3.87 -95.90%
52W Low0.11 42.97%
Volatility14.35% 16.35%
ATR (14)0.03
RSI (14)31.65
Beta0.57
Rel Volume0.13
Avg Volume1.95M
Volume80,764

Performance

Perf Week0.32%
Perf Month-23.52%
Perf Quarter-72.15%
Perf Half Y-85.03%
Perf YTD-91.98%
Perf Year-95.66%
Perf 3Y-94.94%
Perf 5Y-99.79%
Perf 10Y-99.98%
Recom1.00
Target Price12.00
Prev Close0.17
Price0.16
Change %-3.82%

Analyst ratings

latest 4 of 4
DateActionAnalystRating changeTargetImplied
Aug 17, 2020ReiteratedHH.C. WainwrightBuy$14 → $12+7,461.4%
May 12, 2017DowngradePPiper JaffrayOverweight → Neutral
Jun 09, 2015InitiatedPPiper JaffrayOverweight$10+6,201.2%
Jun 09, 2015InitiatedCCredit SuisseOutperform$14+8,721.7%

Peers

Mkt cap
TickerCompanyMkt cap
COCOVita Coco Company Inc3.73B
LSFLaird Superfood Inc28.10M
BOFBranchOut Food Inc32.25M
INGRIngredion Inc5.71B
BRLSBorealis Foods Inc22.00M
CASKSempreon Inc375.59M
BIOXBioceres Crop Solutions Corp14.04M
ZVIAZevia PBC92.86M
CBUSCibus Inc87.89M
BRFHBarfresh Food Group Inc8.32M

Held by

AUM
TickerCompanyAUM
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 206
  • Arcadia Biosciences: Q2 Earnings Snapshot (Associated Press) -18.59% +9.60%
  • Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights (GlobeNewswire)
  • Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -10.84%
  • Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) +18.44%
  • Arcadia Biosciences: Q1 Earnings Snapshot (Associated Press) -10.69%
  • Loading…
  • Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights (GlobeNewswire)
  • Arcadia Biosciences: Q4 Earnings Snapshot (Associated Press Finance) -10.54%
  • Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights (GlobeNewswire)
  • Arcadia Biosciences (RKDA) Announces Exercise of Preferred Investment Options for $2.1 Million Gross Proceeds (GlobeNewswire) -11.64%
  • Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources (GlobeNewswire) -14.47%
  • Arcadia Biosciences: Q3 Earnings Snapshot (Associated Press Finance) -5.38%
  • Arcadia Biosciences (RKDA) Announces Third Quarter 2025 Financial Results and Business Highlights (GlobeNewswire)
  • Arcadia Biosciences: Q2 Earnings Snapshot (Associated Press Finance) +5.56%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-08-13-2.090-0.6301.44--
2026Q12026-05-14-2.110--2.1051.10--
2025Q42026-03-26---0.9760.90--
2025Q32025-11-07-0.848-0.5400.6241.301.901
2025Q22025-08-14-3.260-0.790-3.2611.461.601
2025Q12025-05-081.900-0.9801.9021.201.301
2024Q42025-03-20-2.980-0.890-2.9771.221.151
2024Q32024-11-12-1.180-0.810-1.1821.541.402
2024Q22024-08-130.7801.5500.7791.310.952
2024Q12024-05-09-1.780-2.215-1.7791.261.202
2023Q42024-03-28-2.100-2.585-2.2201.171.752
2023Q32023-11-09-1.890-2.930-1.8881.601.552
2023Q22023-08-100.610-4.8450.6021.391.602
2023Q12023-05-11-7.985-6.850-10.8561.511.402
2022Q42023-03-30-6.310-6.800-6.8891.002.001
2022Q32022-11-10-4.800-8.400-4.6711.882.672

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2015FY-584-372-5845.418.95
2016FY-352-328-3523.193.60
2017FY-291.2--291.384.03-
2018FY-143.23-174.8-143.161.461.30
2019FY-181.14-172-181.081.171.34
2020FY-26.833-85.200-18.6978.032.16
2021FY-102.92-23.600-27.5566.787.94
2022FY-30.980-26.400-25.6539.9611.00
2023FY-16.554-9.725-11.3035.336.25
2024FY-3.170-1.100-5.1635.054.98
2025FY-1.710--3.1704.86-
2026FY--2.420--7.70

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2025-11-061002.402.402.40
2026Q3S2025-11-051002.402.402.40
2026Q3S2025-11-041002.402.402.40
2026Q3S2025-11-031002.402.402.40
2026Q3S2025-11-021002.402.402.40
2026Q3S2025-11-011002.402.402.40
2026Q3S2025-10-311002.402.402.40
2026Q3S2025-10-301002.402.402.40
2026Q3S2025-10-291002.402.402.40
2026Q3S2025-10-281012.402.402.40
2026Q3S2025-10-271012.402.402.40
2026Q3S2025-10-261012.402.402.40
2026Q3S2025-10-251012.402.402.40
2026Q3S2025-10-241012.402.402.40

Estimate history

EPS, annual-291.384-143.16-181.075-18.697-27.556-25.653-11.303-5.163-1.71-4.551
Period201720182019202020212022202320242025TTM
EPS, quarterly0.779-1.182-2.9771.902-3.2610.624-0.976-2.105-2.094
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual4.0261.4641.1698.0346.787.4184.4545.0454.8584.75
Period201720182019202020212022202320242025TTM
Sales, quarterly1.3061.5371.2161.21.4551.3020.9011.11.443
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual0.0530.1190.2160.3360.5550.6161.2851.3651.3732.182
Period201720182019202020212022202320242025MRQ
Shares, quarterly1.3631.3651.3651.3671.3671.3671.3732.0572.182
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue4.754.865.044.457.426.788.031.171.46
Cost of Goods Sold Incl. D&A3.103.102.962.176.108.715.200.890.66
Gross Profit1.641.762.082.281.32-1.932.830.280.80
Selling, General and Administrative Excl. Other5.7011.767.698.3016.5525.9824.3620.6617.67
Research and Development-0.010.050.061.513.897.967.106.07
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-4.06-9.99-5.61-6.02-15.23-27.91-21.52-20.38-16.87
Interest Expense0.000.000.000.000.000.020.050.010.00
Unusual Expense4.03-4.383.51-0.35-2.98-2.94-5.878.24-9.56
Net Income Before Taxes-11.12-2.33-4.31-5.32-10.81-16.13-6.15-28.87-13.47
Income Taxes0.010.010.010.010.010.00-0.120.000.01
Consolidated Net Income-11.13-2.34-4.32-5.33-10.83-16.13-6.03-28.87-13.48
Net Income From Continuing Operations-11.13-2.34-4.32-5.32-10.59-14.66-4.66-28.80-13.48
Net Income-11.13-2.34-7.04-13.98-15.38-14.66-4.66-28.80-13.48
EPS (Recurring)-2.78-3.95-3.36-11.50-29.13-31.43-35.19-144.80-214.24
EPS (Basic, Before Extraordinaries)-4.55-1.71-5.16-11.30-25.65-27.56-18.70-181.07-143.16
EPS (Diluted)-4.55-1.71-5.16-11.30-25.65-27.56-18.70-181.07-143.16
EBITDA-4.04-9.84-4.85-5.03-13.87-26.86-20.86-20.19-16.72
Non-Operating Income (Expense)-3.043.284.810.341.448.859.55-0.24-6.16
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.100.180.400.570.871.121.491.671.22
Price To Sales Ratio0.430.561.600.870.883.263.1429.838.16
Gross Margin34.5836.2341.2751.1917.75-28.4435.2924.2954.85
Operating Margin-85.52-205.74-111.24-135.11-205.28-411.58-267.92-1,743.46-1,152.32
Net Margin-234.53-48.15-139.50-313.90-207.28-216.22-57.94-2,464.07-920.77
Shares Outstanding2.181.371.361.290.620.550.340.220.12
Market Capitalization0.400.408.081.936.6823.0534.0047.3315.12

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue1.441.100.901.301.461.201.221.54
Cost of Goods Sold Incl. D&A0.810.700.710.880.820.680.831.03
Gross Profit0.630.400.190.420.630.520.390.51
Selling, General and Administrative Excl. Other1.131.181.571.836.621.740.672.27
Research and Development0.00--0.000.010.000.010.02
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-0.50-0.78-1.38-1.41-5.99-1.22-0.28-1.76
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense2.992.11-0.51-0.56-0.45-2.863.97-0.33
Net Income Before Taxes-6.27-4.38-1.330.86-4.462.60-4.03-1.18
Income Taxes0.000.000.010.000.000.000.010.00
Consolidated Net Income-6.27-4.38-1.340.86-4.462.60-4.04-1.18
Net Income From Continuing Operations-6.27-4.38-1.340.86-4.462.60-4.04-1.18
Net Income-6.27-4.38-1.340.86-4.462.60-4.06-1.61
EPS (Recurring)-1.39-1.40-1.240.34-3.490.44-0.94-1.35
EPS (Basic, Before Extraordinaries)-2.09-2.11-0.980.63-3.261.90-2.98-1.18
EPS (Diluted)-2.09-2.11-0.980.62-3.261.90-2.98-1.18
EBITDA-0.50-0.77-1.37-1.40-5.96-1.10-0.11-1.57
Non-Operating Income (Expense)-2.78-1.50-0.461.711.080.960.220.25
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.010.010.010.050.090.080.090.15
Price To Sales Ratio0.430.600.560.921.090.771.520.71
Gross Margin43.7336.3621.3132.1043.3743.1731.9932.86
Operating Margin-34.37-70.82-152.61-108.22-411.68-101.67-22.94-114.51
Net Margin-434.23-398.64-148.2865.75-306.39216.58-334.21-104.88
Shares Outstanding2.182.061.371.371.371.371.361.36
Market Capitalization0.402.842.724.745.894.068.081.68

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments4.564.2411.6420.6428.6825.6725.3321.8213.02
Short Term Receivables0.423.070.511.221.371.410.600.171.24
Inventories1.210.900.842.324.433.811.790.180.23
Other Current Assets0.161.031.991.210.900.810.710.700.56
Total Current Assets6.369.2414.9725.4035.3931.7028.4422.8815.05
Net Property, Plant & Equipment0.010.180.862.535.379.373.760.400.30
Total Investments and Advances0.000.000.000.000.002.000.000.000.00
Long-Term Note Receivable0.003.970.00------
Intangible Assets0.040.040.040.040.480.780.000.000.00
Other Assets0.140.093.830.962.673.510.370.751.22
Total Assets6.5513.5219.7028.9243.9247.3532.5724.0216.57
Short Term Debt Incl. Current Port. of LT Debt0.000.150.851.011.071.860.640.000.00
Accounts Payable1.450.700.480.911.410.730.490.280.37
Income Tax Payable-------0.000.02
Other Current Liabilities0.611.712.252.292.563.734.582.773.13
Total Current Liabilities2.062.563.594.215.046.315.713.053.52
Long Term Debt0.000.000.151.012.227.491.600.000.00
Provision for Risks Charges0.000.000.000.002.072.282.000.000.00
Other Liabilities0.354.733.262.813.392.7114.948.155.04
Total Liabilities2.417.297.008.0212.7218.8024.2511.218.56
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity4.146.2212.8421.0331.0927.737.7112.818.01
Total Shareholders Equity4.146.2212.8421.0331.0927.737.7112.818.01
Accumulated Minority Interest0.000.00-0.14-0.130.100.830.620.000.00
Total Equity4.146.2212.7020.9031.2028.558.3312.818.01
Total Liabilities & Stockholders Equity6.5513.5219.7028.9243.9247.3532.5724.0216.57
Book Value Per Share3.024.569.9934.1456.0682.4535.65107.35150.07
Tangible Book Value Per Share2.994.539.9634.0855.1980.1335.65107.35150.07
Full-Time Employees8921305858614442
Price to Book Ratio0.570.790.220.270.741.236.141.181.10
Return on Assets-23.32-25.99-21.90-29.08-32.13-11.65-101.79-66.41-42.95
Return on Equity-45.14-45.29-31.43-40.64-49.85-26.28-280.75-129.48-104.00
Return on Invested Capital-56.50-113.10-107.58-69.76-44.01-13.22-309.43-105.19-196.17
Quick Ratio2.503.253.945.486.144.424.677.434.20
Current Ratio3.093.614.176.037.025.024.987.494.27

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-11.13-2.34-7.04-13.99-15.61-16.13-6.03-28.87-13.48
Depreciation0.020.150.770.981.361.040.660.900.15
Other Funds (Non Cash)7.45-2.53-1.911.220.15-6.52-12.3711.37-1.34
Funds from Operations-3.66-4.71-8.18-11.79-14.10-21.61-17.84-16.61-14.67
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital1.13-0.03-1.45-3.510.12-4.26-12.37-0.061.04
Cash from Operating Activities-2.54-4.74-9.63-15.29-13.98-25.87-30.22-16.67-13.63
Capital Expenditures0.000.00-2.02-0.01-0.07-1.01-2.33-1.48-0.25
Net Assets From Acquisitions0.000.000.000.000.00-4.25-0.500.000.00
Sale of Fixed Assets and Businesses0.000.000.330.681.490.771.590.700.01
Purchase or Sale of Investments0.000.005.02-5.020.0021.8520.11-6.91-5.74
Purchase of Investments0.000.000.00-7.530.000.00-1.29-28.36-29.89
Sale Or Maturity of Investments0.000.005.022.500.0021.8521.4021.4524.15
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.754.000.000.000.000.000.000.00
Cash from Investing Activities0.000.757.34-4.341.4217.3618.86-7.68-5.97
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock5.340.010.015.514.5223.3016.7721.3022.48
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock5.340.010.015.514.5223.3016.7721.3022.48
Proceedsfrom Stock Options5.340.000.01-0.484.5123.237.3516.0221.51
Issuance or Reduction of Debt, Net0.000.000.000.000.00-2.153.07-0.010.00
Change in Long Term Debt0.000.000.000.000.00-2.153.07-0.010.00
Issuance of Long Term Debt0.000.000.000.000.000.003.110.000.00
Reduction of Long Term Debt0.000.000.000.000.00-2.15-0.03-0.010.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00-0.860.000.00
Other Financing Activities Uses0.000.000.000.000.000.00-0.860.000.00
Cash from Financing Activities5.340.010.015.514.5221.1518.9821.3022.48
Exchange Rate Effect----0.000.00---
Net Change in Cash2.80-3.98-2.28-14.13-8.0412.647.63-3.582.87
Free Cash Flow-2.54-4.74-9.64-15.30-14.05-26.88-32.55-18.14-13.88
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.00-0.110.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments4.183.724.565.884.443.16
Short Term Receivables0.560.420.420.831.263.58
Inventories0.930.841.211.461.491.28
Other Current Assets0.070.180.160.210.380.82
Total Current Assets5.745.176.368.397.588.85
Net Property, Plant & Equipment0.000.000.010.010.020.05
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets0.040.040.040.040.040.04
Other Assets0.120.120.140.150.150.09
Total Assets5.895.326.558.587.7912.99
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.010.02
Accounts Payable1.381.101.792.021.561.90
Other Current Liabilities0.260.260.270.270.270.30
Total Current Liabilities1.651.362.062.291.842.22
Long Term Debt0.000.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities3.611.070.350.861.421.87
Total Liabilities5.262.442.413.143.254.08
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity0.632.884.145.444.538.90
Total Shareholders Equity0.632.884.145.444.538.90
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity0.632.884.145.444.538.90
Total Liabilities & Stockholders Equity5.895.326.558.587.7912.99
Book Value Per Share0.291.403.023.983.326.51
Tangible Book Value Per Share0.271.382.993.953.296.49
Full-Time Employees--8---
Price to Book Ratio0.570.460.501.050.660.65
Return on Assets-162.72-101.82-23.32-42.31-56.27-5.30
Return on Equity-430.93-158.15-45.14-64.08-87.18-7.89
Return on Invested Capital-989.89-151.99-32.2715.73-98.3529.19
Quick Ratio2.923.172.503.033.313.41
Current Ratio3.493.793.093.674.123.99

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-6.27-4.38-1.340.86-4.462.60
Depreciation0.000.010.000.010.030.12
Other Funds (Non Cash)5.773.66-0.03-1.953.06-3.60
Funds from Operations-0.49-0.72-1.36-1.09-1.37-0.89
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.18-0.380.500.83-0.66-0.70
Cash from Operating Activities-0.32-1.10-0.86-0.26-2.03-1.59
Capital Expenditures0.000.000.000.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.00-0.500.50
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.00-0.500.50
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.750.00
Cash from Investing Activities0.000.000.000.000.250.50
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock3.541.790.000.000.000.01
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock3.541.790.000.000.000.01
Proceedsfrom Stock Options3.541.790.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities3.541.790.000.000.000.01
Net Change in Cash3.220.69-0.86-0.26-1.78-1.08
Free Cash Flow-0.32-1.10-0.86-0.26-2.03-1.59

Revenue breakdown

License2024: 7.00K
Product2024: 5.01M 2025: 4.86M
Royalty2024: 26.00K
Argentina2024: 26.00K
Canada2024: 109.00K
India2024: 7.00K
United States2024: 4.90M 2025: 4.86M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-305.69%0.1M2.0M1.94M
2026-10-1516.89%0.3M2.0M1.81M
2026-09-304.37%0.1M2.0M928.72K
2026-09-150.40%0.0M2.4M130.57K
2026-08-310.78%0.0M2.4M2.10M
2026-08-143.68%0.1M2.4M3.09M
2026-07-310.15%0.0M2.4M3.04M
2026-07-150.44%0.0M2.2M3.10M
2026-06-301.07%0.0M2.2M3.03M
2026-06-1513.32%0.3M2.1M2.97M
2026-05-2920.06%0.4M2.1M1.02M
2026-05-150.44%0.0M2.1M36.23K
2026-04-300.31%0.0M2.1M31.79K
2026-04-150.08%0.0M2.1M30.03K
2026-03-310.05%0.0M2.0M33.08K
2026-03-131.38%0.0M1.7M32.50K
2026-02-270.95%0.0M1.7M22.09K
2026-02-130.92%0.0M1.7M21.86K
2026-01-300.80%0.0M1.4M24.08K
2026-01-150.68%0.0M1.4M41.15K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-09-30SCHEDULE 13GSEC
2026-09-30S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-09-158-KCurrent report2026-09-10SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-048-KCurrent report2026-08-31SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-138-KCurrent report2026-08-13SEC
2026-08-10ARSAnnual report to security holders. 2025-12-31SEC
2026-08-10DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-08-10SEC
2026-08-108-KCurrent report2026-08-04SEC
2026-07-31PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342025-12-31SEC
2026-07-09424B3SEC
2026-07-08EFFECTEffectiveness filing by commission orderSEC
2026-07-028-KCurrent report2026-07-01SEC
2026-06-26DNotice of sales of securities on Form D (Regulation D)SEC
2026-06-26S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-06-158-KCurrent report2026-06-11SEC
2026-05-15SCHEDULE 13GSEC
2026-05-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-148-KCurrent report2026-05-14SEC
2026-04-3010-K/A2025-12-31SEC
2026-04-038-KCurrent report2026-03-30SEC
2026-03-2610-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-03-268-KCurrent report2026-03-26SEC
2026-02-11424B3SEC
2026-02-10EFFECTEffectiveness filing by commission orderSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
HRT FINANCIAL LP4.30%
CITADEL ADVISORS LLC1.15%
Virtu Financial LLC1.06%
XTX Topco Ltd0.75%
GEODE CAPITAL MANAGEMENT, LLC0.67%
StoneX Group Inc.0.67%
STATE STREET CORP0.59%
JANE STREET GROUP, LLC0.50%
VANGUARD CAPITAL MANAGEMENT LLC0.47%
Bullock Wealth Management Group0.04%

Funds

Fund% owned
iShares Core International Aggregate Bond ETF9.17%
Fidelity Extended Market Index Fund0.51%
VANGUARD EXTENDED MARKET INDEX FUND0.47%
Fidelity Series Total Market Index Fund0.07%
Fidelity Total Market Index Fund0.07%

OakChart. RKDA. Cached 15 minutes.

Some panels did not load: insider.